SUMMARY Mongolian gerbils were treated with alpha-methyl-para-tyrosine methyl ester (AMPT, a tyrosine hydroxylase inhibitor), in order to decrease brain levels of catecholamines. Six hours later, unilateral ischemic stroke was induced by ligation of the left common carotid artery. The delayed degeneration of nerve terminals was studied sixteen hours later by measuring the high-affinity uptake of radiolabeled transmitters by isolated synaptosomes. Dopamine, serotonin and glutamate terminals were studied. AMPT-treated gerbils were compared to untreated (no AMPT) animals; 220 gerbils were studied. AMPT pretreatment (100, 250 and 400 mg/kg) produced a dose-dependent protection of all three types of nerve terminals. In the absence of AMPT pretreatment, the uptake of radiolabeled transmitters by the ischemic hemisphere, expressed as a percentage of that seen in the contralateral (unaffected) side of the brain, was as follows (mean ± SEM): 27.3 ± 5.2% for dopamine terminals, 49.5 ± 6.2% for serotonin terminals, and 42.7 ± 5.3% for glutamate terminals. Protection was essentially complete at a dose of 400 mg AMPT per kg. The number of animals with significant damage to nerve terminals was reduced from 38.5% in untreated animals to 11.1% in animals treated with AMPT 400 mg/kg. Although the nerve terminals were protected, gerbils still showed the behavioral signs of unilateral stroke due to the permanent occlusion of the left carotid. These results indicate that endogenous dopamine may play a significant role in ischemic damage to nerve terminals in the cerebrum. Stroke Vol 16, No 5, 1985 THE MEASUREMENT of high affinity uptake of radiolabeled neurotransmitters by isolated synaptosomes can be used to evaluate damage to nerve terminals in experimental animals with cerebral ischemia. The uptake and accumulation of neurotransmitter against a concentration gradient is a complex neuronal function that requires energy and the structural integrity of the axonal membrane. The neuronal cell type is specified by the high-affinity binding of neurotransmitter to the axonal transport system. Prior studies have determined that the catecholamine nerve terminals that take up dopamine (DA) and norepinephrine (NE) are damaged to a significantly greater degree by cerebral ischemia than terminals incorporating serotonin (5-HT), GABA or glutamate. 1 -2 All nerve terminals were able to function normally in vitro when synaptosomes were isolated for up to eight hours after carotid ligation.
1
- 2 In the Mongolian gerbil, unilateral cerebral ischemia can be induced by unilateral carotid ligation in about 40% of the animals. 3 - 4 These animals have an incomplete Circle of Willis. Thus, they do not receive adequate collateral circulation from the contralateral carotid artery and they suffer a hemispheric stroke.
-4
The uptake and accumulation of neurotransmitter against a concentration gradient is a complex neuronal function that requires energy and the structural integrity of the axonal membrane. The neuronal cell type is specified by the high-affinity binding of neurotransmitter to the axonal transport system. Prior studies have determined that the catecholamine nerve terminals that take up dopamine (DA) and norepinephrine (NE) are damaged to a significantly greater degree by cerebral ischemia than terminals incorporating serotonin (5-HT), GABA or glutamate. 1 -2 All nerve terminals were able to function normally in vitro when synaptosomes were isolated for up to eight hours after carotid ligation. 1 However, by sixteen hours, severe reduction in uptake had occurred. Since the potassium-stimulated release of radiolabeled transmitter proceeded normally, the reduction in uptake appeared to be due to loss of terminals, rather than to reduced uptake in existing terminals. This reduction in uptake probably represents irreversible damage to the nerve terminals because function cannot be restored by incubation in vitro with adequate supplies of substrate and oxygen.
Measurement of the levels of transmitters in the ischemic hemisphere of gerbils with irreversible unilateral carotid occlusion have shown a similar selective reduction of catecholamines relative to the other transmitters. 5 The reduction occurred by one hour after carotid ligation 5 and was attributed to release of the catecholamine transmitters due to depolarization of membranes in ischemia. 6 " 8 The loss of catecholamines has been corroborated by histofluorescence studies, which have shown depletion of catecholamine-derived fluorescence from the ischemic striatum in gerbils with stroke. 9 The present study was instituted to determine whether the selective sensitivity of catecholamine nerve terminals to ischemia could reflect a toxic action mediated by the physical presence of the catecholamine transmitters. Alpha-methyl-para-tyrosine methyl ester (AMPT) was administered to gerbils in order to deplete the brain catecholamine stores. AMPT is a tyrosine hydroxylase inhibitor that prevents synthesis of catecholamines. 10 AMPT reduces catecholamine levels because catecholamines turned over in the course of neurotransmission and metabolism cannot be replaced by resynthesis. 10 Uptake of the transmitters DA, 5-HT and glutamate was measured in synaptosomes isolated from gerbils at sixteen hours after unilateral carotid artery ligation. Animals pretreated with AMPT at six hours prior to unilateral carotid artery ligation were compared to animals that were not pretreated. In this way, the role of endogenous catecholamines in nerve terminal damage could be assessed.
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after injection. 8 Time course studies in guinea pigs injected with 80 mg AMPT/kg i.p. show a peak effect on reduction of brain catecholamine levels at 8 hours, with resynthesis occurring at 24 hours. 10 Gerbils were anesthetized with approximately 40 mg methohexital/kg (i.p.), with the dosage titrated to the stage of surgical anesthesia for each animal. Animals could breathe spontaneously without a respirator. The left common carotid artery was exposed in the paratracheal region by blunt dissection so that there was no blood loss. After the animals exhibited partial recovery from anesthesia to the extent that they were responsive to leg pinch, the carotid artery was ligated with two ties. This method has been employed by Lust et al 5 to provide animals in whom behavioral changes associated with clinical stroke could be readily observed.
The behavioral criteria for designation of stroke were similar to those described by Kahn: 3 paucity of movement or splaying of the contralateral extremities (hemiparesis), torsion of the body and circling to the left, obtundation and a comatose-like motionless state. Animals that appeared otherwise normal but exhibited mild circling behavior generally associated with some lethargy were classified as "circling." The "circling" category included some gerbils with such mild behavioral changes that the final categorization was difficult.
At sixteen hours after carotid ligation, the gerbils were decapitated with a guillotine. The cerebrum was removed and separated into left and right hemispheres, which were immediately immersed in ice cold isotonic (0.9%) saline. This procedure took approximately 30 seconds. Each hemisphere was weighed and then homogenized in 10 ml of 0.32M sucrose. Centrifugation was performed in a Sorvall RC 2B refrigerated centrifuge with a SS 34 head. The homogenates were centrifuged at 3000 rpm (1100 x g), for 10 minutes, to remove blood and cellular debris. The supernatant was centrifuged at 15,000 rpm (27,000 x g) for 30 minutes and the pellet retained. The pellet was then resuspended at a concentration of 150 mg wet weight of original tissue per ml in Krebs-Ringer phosphate buffer, pH 7.4, containing 0.05 mM pargyline and 1.7 mM ascorbic acid. This preparation has been used previously to provide a synaptosomal suspension which contains mitochondria, but is relatively free of glial elements and other subcellular particles.'-
Uptake measurements'-n were based on prior studies by other investigators' 3 "
15 and were carried out in triplicate. Aliquots of 200 fil of the synaptosomal preparation in 5 ml of the Krebs-Ringer phosphate buffer were preincubated for 10 minutes at 37°C in a Precision Scientific GCA shaker bath. Radiolabeled neurotransmitters were added to a final concentration of 5 X 10-9 M for DA and 5-HT and 8 X 10-6 M for glutamate. After 10 minutes, one ml aliquots were removed from replicate flasks and passed through a 0.65 /x Millipore filter by means of suction filtration to isolate the synaptosomes. The filters with adhering synaptosomes were washed quickly with 1.0 ml saline. They were then suspended in 10 ml Scintiverse solution for scintillation counting of the radioactivity; radioactivity measurements were made 8-24 hours later in a Packard Model 2450 Tricarb Scintillation Spectrometer. The uptake of radiolabeled transmitters, corrected for radioactivity retained on the filter papers,' was expressed as the DPM per mg wet weight of original tissue divided by the DPM in an equivalent volume of incubation medium, that is, a tissue-to-medium ratio. The uptake of transmitter in the ischemic left side versus the control right side was compared by expressing results as a ratio of left/right (L/R ratio).
Statistical comparisons were made by paired Student "t" test for uptake of transmitters in each animal. The unpaired Student "t" test and the Mann-Whitney rank order U Test were employed for comparison of uptake between AMPT-treated and untreated animals. Chi square analysis was employed to determine if there were any significant behavioral differences in the various treatment groups. Significant reduction in uptake in the ischemic hemisphere of an individual animal was defined as an uptake value more than two standard deviations below the mean uptake in the left hemisphere of unaffected animals not treated with AMPT.
Radiolabeled neurotransmitters were obtained from New England Nuclear (Boston, Mass.): Results Neurotransmitter uptake was measured in synaptosomes prepared from the ischemic left cerebral hemisphere and control right cerebral hemisphere of gerbils subjected to left carotid ligation (table 1). Uptake was measured at 16 hours after carotid ligation. Animals were separated into the following groups: those with no behavioral change (unaffected), those with mild behavioral changes such as slight lethargy and intermittent circling (circle), and those with hemiparesis and rotational movement (stroke). The behavioral characteristics of the animals are described in table 2.
Animals pretreated with AMPT were generally slightly lethargic six hours later when carotid ligation was performed. By 16 hours after ligation, animals treated with AMPT 100 mg/kg and 250 mg/kg that did not have a stroke were behaviorally indistinguishable from untreated animals without stroke. Animals without stroke that were pretreated with AMPT 400 mg/kg were hypokinetic, slightly lethargic, and tremulous 16 hours after carotid ligation, but would walk when prodded and could stand on their hind legs when disturbed.
Animals that were pretreated with AMPT 100 mg/kg and suffered a stroke after carotid ligation displayed the same behavioral activity as untreated animals with stroke (see methods). Animals with stroke pretreated with AMPT 400 mg/kg showed a somewhat The uptake of DA, 5-HT and glutamate into synaptosomes from the ischemic (left) hemisphere and control (right) hemisphere is shown at 16 hours after left carotid ligation in gerbils pretreated with varying doses of AMPT. Uptake is expressed as the tissue to medium ratio: the disintegrations per minute (dpm)/mg wet weight of original tissue divided by the dpm in an equivalent volume of incubation medium. tThere is an apparent decrement in uptake of 5-HT in unaffected animals treated with AMPT 400 mg/kg. However, several untreated animals studied at the same time as controls had similar tissue to medium uptake ratios. The lower 5-HT uptake in these animals (both with and without AMPT) reflects decomposition of the 3 H-5-HT tracer, rather than an effect of AMPT on uptake. Expression of the data as Left/Right ratio compensates for the effect of radiotracer decomposition and permits evaluation of the effects of ischemia in the various subgroups. It should be noted that earlier studies did not show bilateral change in uptake of neurotransmitters.
24
-25 different behavior. Eight of these animals were curled in a ball, hypotonic and lying at the bottom of the cage because they could not support weight with their right extremities. Three animals that were standing, but hunched over, were classified as having a stroke because they had spastic extension of the right extremities when lifted by the tail and could not maintain standing balance when pushed. Four animals that also curled in a ball but had normal responses when lifted by the tail and good righting reflexes when pushed were put into the intermediate classification (circling). In these four animals, it could not be distinguished whether the paucity of movement was secondary to cerebral ischemia or to the metabolic effects of AMPT. None of the animals with stroke in the 400 mg AMPT/kg group exhibited rotational movement as seen in untreated animals. Lack of rotation may have been due to depletion of dopamine by AMPT in the unaffected striatum.
Two stroke animals pretreated with AMPT 250 The number of gerbils affected with stroke or mild circling, or unaffected, after left carotid ligation is shown at varying dosages of AMPT. Intraoperative deaths were due to respiratory or cardiac arrest during surgery. An apparent increase in intraoperative deaths at the higher doses of AMPT may have been the result of compromise of sympathetic tone due to depletion of catecholamines; however, the difference was not statistically significant by Chi-square analysis. Most of the deaths due to stroke occurred 2-3 hours after carotid ligation and were secondary to seizures. The gerbils were not continuously observed for the whole 16 hour period following carotid ligation. Therefore, the number of gerbils having seizures in the AMPT-treated and untreated groups could not be quantitatively compared. There were no significant differences in the total number of animals with stroke (i.e. stroke plus death due to stroke) in any of the treatment groups by Chi-square analysis. No other differences were significant. mg/kg behaved in a similar fashion to the eight stroke animals pretreated with AMPT 400 mg/kg. Five stroke animals pretreated with AMPT 250 mg/kg behaved like untreated stroke animals.
Inspection of the brains of animals pretreated with AMPT 250 mg/kg and 400 mg/kg that exhibited stroke behavior revealed evidence of tissue necrosis in the cortex, but less softening of subcortical structures than untreated animals with stroke. This was clearly evident on removing the cerebrum from the cranium and separating the hemispheres. The diminution in the extent of necrosis was present even in animals where uptake of transmitter was impaired.
Uptake of DA into synaptosomes prepared from the ischemic (left) hemisphere of 10 untreated gerbils with stroke was significantly more impaired than uptake of 5-HT or glutamate (table 1), (p < 0.001). These results confirm earlier observations 1 ' 2 on the selective sensitivity of DA neurons. Uptake of DA was 27.3 ± 5.2% of the control hemisphere, (see left/right ratio) while uptake of 5-HT was 49.5 ± 6.2% and uptake of glutamate was 42.7 ± 5.3%. Uptake of each transmitter was significantly reduced relative to control (p < 0.001).
In nine gerbils with stroke that were pretreated with the lower dose of AMPT (100 mg/kg), uptake of DA was 40.9 ± 12.7% of the control side. Uptake of 5-HT was 52.5 ± 9.3% and uptake of glutamate was 53.2 ± 10.4%. Uptake of all three transmitters was significantly lower in synaptosomes from the ischemic hemisphere than from the control hemisphere (DA p < 0.005, 5-HT p < 0.05, glutamate p < 0.025). However, the differences between relative uptake of the three transmitters were no longer statistically significant.
In seven gerbils with stroke treated with the intermediate dose of AMPT (250 mg/kg), uptake of DA into synaptosomes from the ischemic hemisphere was 54.2 ± 14.7% of control. Uptake of 5-HT was 67.5 ± 13.0% and uptake of glutamate was 63.7 ± 13.2%. Again, uptake of all three transmitters was significantly reduced compared to the control side (p < 0.05), but the differences between DA and the other transmitters did not achieve statistical significance.
In eleven gerbils with stroke that had been treated with the high dose of AMPT (400 mg/kg), uptake of DA into synaptosomes from the ischemic hemisphere was 81.8 ± 10.8% of control, uptake of 5-HT was 88.5 ± 7.9% and uptake of glutamate was 87.9 ± 9.1 %. At this dosage of AMPT, uptake of each transmitter was not significantly different from its respective control. Moreover, AMPT provided significant protection for all three types of nerve terminals (DA p < 0.001, 5-HT/? < 0.005, glutamate/? < 0.001 by ttest; p < 0.01 by Mann-Whitney U Test).
There was no significant difference between untreated and AMPT-treated animals in the uptake of transmitters in unaffected animals (table 1) . Thus, AMPT did not appear to have a direct effect on uptake. The reduction in the endogenous concentration of DA by AMPT does not alter the accumulation of 3 H-DA by synaptosomes because the concentration added to the medium is well below the Km of uptake for DA. 15 In this range, transport is proportional to the concentration used.
The uptake of DA ( fig. la) In stroke animals pretreated with 100 mg AMPT/kg, five of nine showed this same significant reduction in transmitter uptake with accentuation of damage to DA terminals. The remaining animals showed considerable preservation of DA nerve terminal function. Inspection of tabular data for individual animals (not shown), revealed that when uptake of DA was preserved, uptake of 5-HT and glutamate was also increased relative to control stroke animals.
In stroke animals pretreated with 250 mg AMPT/kg, only two of seven animals showed a significant reduction in DA uptake. For three animals, DA uptake approached equality with uptake in the non-ischemic right hemisphere. In these animals, uptake of 5-HT and glutamate also were elevated to the level seen in the control hemisphere. In stroke animals that had been pretreated with 400 mg AMPT/kg, only two of eleven animals had significant reduction in DA uptake into synaptosomes from the ischemic hemisphere, and one animal had intermediate reduction. These three animals correspond to the lowest data points for 5-HT and glutamate uptake in Figs, lb and lc. In the remaining eight animals, uptake of DA, 5-HT and glutamate in the ischemic hemispheres were all in the same range as in the corresponding non-ischemic hemispheres.
We considered the possibility that the sedative effect of AMPT 400 mg/kg may have caused animals with mild stroke to appear as if they had a more severe stroke. In such an event, mildly affected animals would be placed into the "stroke" category and the mean uptake value in the stroke category would given an appearance of protection. However, this possibility can be excluded: Only 3 of 27 animals treated with AMPT 400 mg/kg had significant impairment of uptake of DA in the ischemic hemisphere. For animals not pretreated with AMPT, all 10 with stroke and 5 of 7 with mild circling behavior had significant reduction of uptake of DA in the ischemic hemisphere. A comparison of the AMPT-pretreated and untreated groups shows that the total number of animals with significant damage to nerve terminals in the pretreated group (3/27 11.1%) was significantly lower than among untreated animals (15/39 38.5%) (p < 0.01), irrespective of the extent of stroke behavior.
In summary, when there was prevention of damage to DA nerve terminals by AMPT, there was also prevention of damage to 5-HT and glutamate terminals. Protection by AMPT was dose-dependent upon the administered amount of AMPT: Both the mean uptake values for animals in the stroke category (table 1) , and the number of animals exhibiting preservation of neurotransmitter uptake ( fig. 1) , increased with increasing dose of AMPT. Although AMPT protected against the loss of neurotransmitter uptake, it did not prevent behavioral change associated with stroke after permanent ligation of the carotid artery (table 2) .
With regard to the possibility of selective protection of DA terminals by AMPT, the simultaneous effects 
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on DA, 5-HT, and glutamate terminals makes a clear evaluation difficult. It is noted that for the lowest dose of AMPT (100 mg/kg), where selectivity in action might be most readily assessed, DA uptake remained less than that for 5-HT or glutamate (table 1, L/R ratio, stroke category), but differences between DA and the other transmitters were no longer significant statistically. Increments in mean uptake of DA and glutamate with increasing AMPT were apparent (table 1, DA from 0.27 ± 0.05 to 0.40 ± 0.12, and glutamate from 0.42 ± 0.05 to 0.53 ± 0.10), while the mean uptake of 5-HT was relatively unchanged (from 0.49 ± 0.06 to 0.52 ± 0.09). J h e increase in SEM for each transmitter (table 1, L/R ratio, 100 mg AMPT/kg), compared to no pretreatment, relates to the greater spread of data, due in large measure to the strong protection seen in some animals (Cf. figs, la, b, c).
Discussion
Treatment of gerbils with AMPT prior to carotid ligation reduced the amount of ischemic damage to the uptake mechanism of DA nerve terminals, as well as to those of 5-HT and glutamate terminals. The number of animals with significant impairment of uptake was reduced from 38.5% in untreated animals to 11.1% in animals treated with AMPT 400 mg/kg. This reduction in damage was significant (p < 0.01). Depletion of the catecholamines did not completely prevent stroke, since animals still exhibited severe behavioral abnormalities. There was also damage to tissue in the cerebral hemispheres on gross inspection, though perhaps to a lesser extent than untreated animals. Since AMPT depletes cerebral catecholamines, these results suggest that the catecholamines are in some way deleterious to nerve terminals after an ischemic insult.
An initial goal of this study was to assess whether or not AMPT could prevent the accentuated damage to DA nerve terminals. As noted, however, the main finding was that AMPT protected all three of the terminal types that were studied. The simultaneous action on DA, 5-HT and glutamate makes it difficult to evaluate any selective degree of protection for DA nerve terminals.
Other authors have reported release of endogenous catecholamines from the brain, shortly after the onset of ischemia. '• 6 " 9 This could result in vasospasm, and in a consequent worsening of the ischemic insult. Furthermore, there is some evidence that extraneuronal catecholamines may be toxic to neuronal structures: When norepinephrine is injected into the capillaries of a pial window, regional necrosis of cerebral tissue occurs. 16 Necrosis does not occur when 5-HT is injected, even with an equivalent amount of regional ischemia. 16 Acute release of endogenous catecholamine does not explain the delayed damage to nerve terminals that occurs after eight hours of ischemia, though it may be involved in the initial damaging process. Indeed, histoflourescence studies have shown almost complete depletion of catecholamine from the ipsilateral striatum early after carotid occlusion in the gerbil. 9 At this time, the structure of the striatum and the function of nerve terminals remain intact. 1 -9 Even though there is depletion of catecholamine in the ischemic hemisphere, there is evidence that catecholamine metabolism and turnover proceed. The levels of catecholamines fall initially and do not rise. 5 However, AMPT 400 mg/kg administered two hours prior to the carotid ligation produces a further decrement in catecholamine level two hours after ligation. 8 Similarly, the administration of the monoamine oxidase (MAO) inhibitor pargyline 75 mg/kg two hours prior to ligation produces a rise in catecholamine levels in the ischemic hemisphere two hours after ligation. 8 These observations also imply that some circulation and oxygen are present in the ischemic hemisphere, since both tyrosine hydroxylase and MAO require molecular oxygen to function. 8 Disruption of nerve terminal function by an ischemic insult appears to be a delayed process analogous to the histologic finding of ripening of ischemic infarction, which occurs in a similar time frame. 17 Some acute injury does occur to neuronal membranes. This can be seen ultrastructurally as a breakdown of ribosomal units and swelling of rough endoplasmic reticulum and Golgi complexes. 18 This initial vacuolization may cause leakage of catecholamine transmitters either into the cytoplasm or extracellularly. Extracellular catecholamines may penetrate into the cytoplasm of neurons and glia. Cytoplasmic catecholamines would be exposed to MAO which produces H 2 O 2 as a product of oxidative deamination. 19 H 2 O 2 is a known neurotoxin and could possibly be involved in the ripening if ischemic damage. Extracellular catecholamines may also exert toxic effects via autoxidation or other mechanisms. Prior depletion of catecholamines and inhibition of catecholamine resynthesis in the ischemic hemisphere may lessen or prevent this damage.
Synaptic activity appears to be necessary to mediate the death of hypoxic neurons in tissue culture. 20 When young hippocampal neurons without synaptic activity are exposed to sodium cyanide or hypoxia, no effect is noted. Death occurs only in more mature neurons that have developed synaptic activity. This hypoxic death can be blocked by MgCl 2 , which inhibits synaptic activity. 20 Our data indicate that catecholamine transmitters are involved in the delayed degeneration of nerve terminals in the ischemic hemisphere of Mongolian gerbils. Depletion of the catecholamines by pretreatment with AMPT exerted a strong protective effect at 16 hours after carotid ligation. The toxicity of catecholamines may be due to a direct action or to some byproduct of catecholamine metabolism. Glutamate and 5-HT nerve terminals were protected along with DA terminals, suggesting that catecholamines may be involved in the spread of ischemic damage to adjacent nerve terminals.
